ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rifaximin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24D10239
Home | Market Reports | Health| Health Conditions
Global and United States Rifaximin Market Report Forecast 2022 2028
BUY CHAPTERS

Global Rifaximin Market Research Report 2025

Code: QYRE-Auto-24D10239
Report
September 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Salix Pharmaceuticals
Soigner Pharma
STERIS PHARMA
Texas Pharmaceuticals
Cassopeia Pharmaceuticals

Rifaximin Market Size

The global market for Rifaximin was valued at US$ 75 million in the year 2024 and is projected to reach a revised size of US$ 102 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Rifaximin Market

Rifaximin Market

Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler"s diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.
Rifaximin is an antibiotic used for the treatment of various conditions such as traveler"s diarrhea and hepatic encephalopathy. The global market for rifaximin is being driven by several factors. Here are some key drivers of the rifaximin market：Increased prevalence of infectious diseases: The global prevalence of infectious diseases is on the rise, due to factors such as globalization, increased travel, and climate change. This has led to a higher demand for effective antibiotics like rifaximin. Growing awareness of antibiotic resistance: Antibiotic resistance is a growing concern worldwide, leading to an increased focus on developing and using antibiotics judiciously. Rifaximin is a non-systemic antibiotic, which means it has a lower risk of contributing to antibiotic resistance. This makes it a preferred choice for some indications. Expanding indications: Rifaximin has received regulatory approvals for the treatment of various conditions, including traveler"s diarrhea, hepatic encephalopathy, and irritable bowel syndrome. The expanding list of approved indications is contributing to the market growth. Advances in healthcare infrastructure: Improvements in healthcare infrastructure, particularly in emerging markets, have increased access to advanced antibiotics like rifaximin. This has led to a wider patient pool and increased market demand. Rising healthcare expenditure: Governments and private entities are investing heavily in healthcare, including the development and distribution of antibiotics. This increased healthcare spending is supporting the availability and affordability of rifaximin, driving market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rifaximin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifaximin.
The Rifaximin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rifaximin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifaximin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rifaximin Market Report

Report Metric Details
Report Name Rifaximin Market
Accounted market size in year US$ 75 million
Forecasted market size in 2031 US$ 102 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 200 mg Tablets
  • 550 mg Tablets
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Salix Pharmaceuticals, Soigner Pharma, STERIS PHARMA, Texas Pharmaceuticals, Cassopeia Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rifaximin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rifaximin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Rifaximin Market growing?

Ans: The Rifaximin Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Rifaximin Market size in 2031?

Ans: The Rifaximin Market size in 2031 will be US$ 102 million.

Who are the main players in the Rifaximin Market report?

Ans: The main players in the Rifaximin Market are Salix Pharmaceuticals, Soigner Pharma, STERIS PHARMA, Texas Pharmaceuticals, Cassopeia Pharmaceuticals

What are the Application segmentation covered in the Rifaximin Market report?

Ans: The Applications covered in the Rifaximin Market report are Hospital, Drug store

What are the Type segmentation covered in the Rifaximin Market report?

Ans: The Types covered in the Rifaximin Market report are 200 mg Tablets, 550 mg Tablets

Recommended Reports

Antibiotic APIs

Infectious Disease Diagnostics

Gastrointestinal Therapeutics

1 Rifaximin Market Overview
1.1 Product Definition
1.2 Rifaximin by Type
1.2.1 Global Rifaximin Market Value Comparison by Type (2024 VS 2031)
1.2.2 200 mg Tablets
1.2.3 550 mg Tablets
1.3 Rifaximin by Application
1.3.1 Global Rifaximin Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Rifaximin Market Size Estimates and Forecasts
1.4.1 Global Rifaximin Revenue 2020-2031
1.4.2 Global Rifaximin Sales 2020-2031
1.4.3 Global Rifaximin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rifaximin Market Competition by Manufacturers
2.1 Global Rifaximin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rifaximin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rifaximin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rifaximin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rifaximin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rifaximin, Product Type & Application
2.7 Global Key Manufacturers of Rifaximin, Date of Enter into This Industry
2.8 Global Rifaximin Market Competitive Situation and Trends
2.8.1 Global Rifaximin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rifaximin Players Market Share by Revenue
2.8.3 Global Rifaximin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rifaximin Market Scenario by Region
3.1 Global Rifaximin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rifaximin Sales by Region: 2020-2031
3.2.1 Global Rifaximin Sales by Region: 2020-2025
3.2.2 Global Rifaximin Sales by Region: 2026-2031
3.3 Global Rifaximin Revenue by Region: 2020-2031
3.3.1 Global Rifaximin Revenue by Region: 2020-2025
3.3.2 Global Rifaximin Revenue by Region: 2026-2031
3.4 North America Rifaximin Market Facts & Figures by Country
3.4.1 North America Rifaximin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rifaximin Sales by Country (2020-2031)
3.4.3 North America Rifaximin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rifaximin Market Facts & Figures by Country
3.5.1 Europe Rifaximin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rifaximin Sales by Country (2020-2031)
3.5.3 Europe Rifaximin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rifaximin Market Facts & Figures by Region
3.6.1 Asia Pacific Rifaximin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rifaximin Sales by Region (2020-2031)
3.6.3 Asia Pacific Rifaximin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rifaximin Market Facts & Figures by Country
3.7.1 Latin America Rifaximin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rifaximin Sales by Country (2020-2031)
3.7.3 Latin America Rifaximin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rifaximin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rifaximin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rifaximin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rifaximin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rifaximin Sales by Type (2020-2031)
4.1.1 Global Rifaximin Sales by Type (2020-2025)
4.1.2 Global Rifaximin Sales by Type (2026-2031)
4.1.3 Global Rifaximin Sales Market Share by Type (2020-2031)
4.2 Global Rifaximin Revenue by Type (2020-2031)
4.2.1 Global Rifaximin Revenue by Type (2020-2025)
4.2.2 Global Rifaximin Revenue by Type (2026-2031)
4.2.3 Global Rifaximin Revenue Market Share by Type (2020-2031)
4.3 Global Rifaximin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rifaximin Sales by Application (2020-2031)
5.1.1 Global Rifaximin Sales by Application (2020-2025)
5.1.2 Global Rifaximin Sales by Application (2026-2031)
5.1.3 Global Rifaximin Sales Market Share by Application (2020-2031)
5.2 Global Rifaximin Revenue by Application (2020-2031)
5.2.1 Global Rifaximin Revenue by Application (2020-2025)
5.2.2 Global Rifaximin Revenue by Application (2026-2031)
5.2.3 Global Rifaximin Revenue Market Share by Application (2020-2031)
5.3 Global Rifaximin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Salix Pharmaceuticals
6.1.1 Salix Pharmaceuticals Company Information
6.1.2 Salix Pharmaceuticals Description and Business Overview
6.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Salix Pharmaceuticals Rifaximin Product Portfolio
6.1.5 Salix Pharmaceuticals Recent Developments/Updates
6.2 Soigner Pharma
6.2.1 Soigner Pharma Company Information
6.2.2 Soigner Pharma Description and Business Overview
6.2.3 Soigner Pharma Rifaximin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Soigner Pharma Rifaximin Product Portfolio
6.2.5 Soigner Pharma Recent Developments/Updates
6.3 STERIS PHARMA
6.3.1 STERIS PHARMA Company Information
6.3.2 STERIS PHARMA Description and Business Overview
6.3.3 STERIS PHARMA Rifaximin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 STERIS PHARMA Rifaximin Product Portfolio
6.3.5 STERIS PHARMA Recent Developments/Updates
6.4 Texas Pharmaceuticals
6.4.1 Texas Pharmaceuticals Company Information
6.4.2 Texas Pharmaceuticals Description and Business Overview
6.4.3 Texas Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Texas Pharmaceuticals Rifaximin Product Portfolio
6.4.5 Texas Pharmaceuticals Recent Developments/Updates
6.5 Cassopeia Pharmaceuticals
6.5.1 Cassopeia Pharmaceuticals Company Information
6.5.2 Cassopeia Pharmaceuticals Description and Business Overview
6.5.3 Cassopeia Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cassopeia Pharmaceuticals Rifaximin Product Portfolio
6.5.5 Cassopeia Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rifaximin Industry Chain Analysis
7.2 Rifaximin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rifaximin Production Mode & Process Analysis
7.4 Rifaximin Sales and Marketing
7.4.1 Rifaximin Sales Channels
7.4.2 Rifaximin Distributors
7.5 Rifaximin Customer Analysis
8 Rifaximin Market Dynamics
8.1 Rifaximin Industry Trends
8.2 Rifaximin Market Drivers
8.3 Rifaximin Market Challenges
8.4 Rifaximin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Salix Pharmaceuticals
Soigner Pharma
STERIS PHARMA
Texas Pharmaceuticals
Cassopeia Pharmaceuticals
List of Tables
 Table 1. Global Rifaximin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rifaximin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rifaximin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rifaximin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rifaximin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rifaximin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rifaximin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rifaximin Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rifaximin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rifaximin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rifaximin, Product Type & Application
 Table 12. Global Key Manufacturers of Rifaximin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rifaximin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rifaximin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rifaximin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rifaximin Sales Market Share by Region (2020-2025)
 Table 19. Global Rifaximin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rifaximin Sales Market Share by Region (2026-2031)
 Table 21. Global Rifaximin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rifaximin Revenue Market Share by Region (2020-2025)
 Table 23. Global Rifaximin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rifaximin Revenue Market Share by Region (2026-2031)
 Table 25. North America Rifaximin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rifaximin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rifaximin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rifaximin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rifaximin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rifaximin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rifaximin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rifaximin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rifaximin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rifaximin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rifaximin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rifaximin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rifaximin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rifaximin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rifaximin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rifaximin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rifaximin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rifaximin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rifaximin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rifaximin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rifaximin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rifaximin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rifaximin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rifaximin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rifaximin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rifaximin Sales (K Units) by Type (2020-2025)
 Table 51. Global Rifaximin Sales (K Units) by Type (2026-2031)
 Table 52. Global Rifaximin Sales Market Share by Type (2020-2025)
 Table 53. Global Rifaximin Sales Market Share by Type (2026-2031)
 Table 54. Global Rifaximin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rifaximin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rifaximin Revenue Market Share by Type (2020-2025)
 Table 57. Global Rifaximin Revenue Market Share by Type (2026-2031)
 Table 58. Global Rifaximin Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Rifaximin Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Rifaximin Sales (K Units) by Application (2020-2025)
 Table 61. Global Rifaximin Sales (K Units) by Application (2026-2031)
 Table 62. Global Rifaximin Sales Market Share by Application (2020-2025)
 Table 63. Global Rifaximin Sales Market Share by Application (2026-2031)
 Table 64. Global Rifaximin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rifaximin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rifaximin Revenue Market Share by Application (2020-2025)
 Table 67. Global Rifaximin Revenue Market Share by Application (2026-2031)
 Table 68. Global Rifaximin Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Rifaximin Price (USD/Unit) by Application (2026-2031)
 Table 70. Salix Pharmaceuticals Company Information
 Table 71. Salix Pharmaceuticals Description and Business Overview
 Table 72. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Salix Pharmaceuticals Rifaximin Product
 Table 74. Salix Pharmaceuticals Recent Developments/Updates
 Table 75. Soigner Pharma Company Information
 Table 76. Soigner Pharma Description and Business Overview
 Table 77. Soigner Pharma Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Soigner Pharma Rifaximin Product
 Table 79. Soigner Pharma Recent Developments/Updates
 Table 80. STERIS PHARMA Company Information
 Table 81. STERIS PHARMA Description and Business Overview
 Table 82. STERIS PHARMA Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. STERIS PHARMA Rifaximin Product
 Table 84. STERIS PHARMA Recent Developments/Updates
 Table 85. Texas Pharmaceuticals Company Information
 Table 86. Texas Pharmaceuticals Description and Business Overview
 Table 87. Texas Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Texas Pharmaceuticals Rifaximin Product
 Table 89. Texas Pharmaceuticals Recent Developments/Updates
 Table 90. Cassopeia Pharmaceuticals Company Information
 Table 91. Cassopeia Pharmaceuticals Description and Business Overview
 Table 92. Cassopeia Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Cassopeia Pharmaceuticals Rifaximin Product
 Table 94. Cassopeia Pharmaceuticals Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Rifaximin Distributors List
 Table 98. Rifaximin Customers List
 Table 99. Rifaximin Market Trends
 Table 100. Rifaximin Market Drivers
 Table 101. Rifaximin Market Challenges
 Table 102. Rifaximin Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rifaximin
 Figure 2. Global Rifaximin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rifaximin Market Share by Type: 2024 & 2031
 Figure 4. 200 mg Tablets Product Picture
 Figure 5. 550 mg Tablets Product Picture
 Figure 6. Global Rifaximin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rifaximin Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug store
 Figure 10. Global Rifaximin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Rifaximin Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Rifaximin Sales (2020-2031) & (K Units)
 Figure 13. Global Rifaximin Average Price (USD/Unit) & (2020-2031)
 Figure 14. Rifaximin Report Years Considered
 Figure 15. Rifaximin Sales Share by Manufacturers in 2024
 Figure 16. Global Rifaximin Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Rifaximin Players: Market Share by Revenue in Rifaximin in 2024
 Figure 18. Rifaximin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Rifaximin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Rifaximin Sales Market Share by Country (2020-2031)
 Figure 21. North America Rifaximin Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Rifaximin Sales Market Share by Country (2020-2031)
 Figure 25. Europe Rifaximin Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Rifaximin Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Rifaximin Revenue Market Share by Region (2020-2031)
 Figure 33. China Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Rifaximin Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Rifaximin Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Rifaximin Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Rifaximin Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Rifaximin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Rifaximin by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Rifaximin by Type (2020-2031)
 Figure 55. Global Rifaximin Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Rifaximin by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Rifaximin by Application (2020-2031)
 Figure 58. Global Rifaximin Price (USD/Unit) by Application (2020-2031)
 Figure 59. Rifaximin Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Rifaximin Tablets Market Research Report 2024
Global Rifaximin Capsules Market Research Report 2024
Global Rifaximin for Suspension Market Research Report 2024
Global Rifaximin API Market Research Report 2024
Rituxan rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nitazoxanide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sulfadoxine Market Insights Forecast to 2030
Global Azithromycin Market Insights Forecast to 2030
Global Xipamide API Market Research Report 2025
Rifampicin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polyoxidonium Market Insights Forecast to 2030
Global Oseltamivir Market Insights Forecast to 2030
Global Roxithromycin Market Insights Forecast to 2030
Global Rivaroxaban Drugs Market Research Report 2024
Global Alinia nitazoxanide Market Research Report 2025
Global Levofloxacin Tablets Market Insights Forecast to 2030
Global Tamiflu Oseltamivir Phosphate Market Insights Forecast to 2030
Global Sulfadimidine Sodium Market Research Report 2024
Global Roxithromycin Tablets Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions